Summary statistics for overall sample population by stage of CKD
Parameter Description | Overall | No CKD | CKD Stage 1 | CKD Stage 2 | CKD Stage 3 | CKD Stage 4 |
---|---|---|---|---|---|---|
Patients (n) | 4148a | 2539 | 161 | 438 | 938 | 56 |
Patients (%) | 100 | 45.3 ± 1.6 | 2.6 ± 0.3 | 9.1 ± 0.6 | 21.0 ± 1.1 | 1.1 ± 0.2 |
Age (yr) | 72.0 ± 0.3 | 70.4 ± 0.3 | 69.0 ± 1.5 | 73.8 ± 0.8 | 76.4 ± 0.5 | 77.2 ± 1.4 |
Women (%) | 55.9 ± 1.0 | 52.9 ± 1.3 | 44.7 ± 5.4 | 56.5 ± 3.3 | 66.6 ± 2.2 | 58.8 ± 9.8 |
Race/ethnicity (%) | ||||||
White | 85.2 ± 1.1 | 86.1 ± 1.2 | 64.9 ± 6.1 | 79.3 ± 2.4 | 88.0 ± 1.4 | 80.1 ± 7.3 |
Hispanic/Latino | 2.2 ± 0.2 | 2.2 ± 0.2 | 5.2 ± 1.0 | 3.0 ± 0.4 | 1.3 ± 0.2 | 1.5 ± 0.8 |
Black | 8.6 ± 1.1 | 7.9 ± 1.2 | 25.5 ± 6.3 | 10.9 ± 2.4 | 7.0 ± 1.4 | 10.2 ± 7.8 |
Diabetes | 13.0 ± 0.6 | 8.8 ± 0.7 | 26.4 ± 5.9 | 25.6 ± 2.9 | 18.5 ± 1.8 | 23.0 ± 7.2 |
Hypertension | 64.6 ± 1.0 | 56.5 ± 1.1 | 75.1 ± 5.5 | 78.6 ± 2.4 | 81.0 ± 1.8 | 94.6 ± 3.4 |
Myocardial infarction | 11.9 ± 1.0 | 9.7 ± 1.1 | 15.1 ± 3.9 | 12.9 ± 2.4 | 17.2 ± 1.8 | 24.3 ± 8.0 |
Stroke | 6.3 ± 0.5 | 4.7 ± 0.6 | 6.5 ± 2.2 | 7.7 ± 1.5 | 10.3 ± 1.4 | 14.7 ± 6.6 |
Congestive heart failure | 7.6 ± 0.6 | 5.1 ± 0.7 | 5.9 ± 2.4 | 9.1 ± 1.6 | 14.2 ± 1.4 | 23.1 ± 9.0 |
Cancer | 20.6 ± 1.1 | 19.1 ± 1.2 | 15.7 ± 3.7 | 25.1 ± 3.1 | 24.1 ± 2.1 | 18.8 ± 6.8 |
Asthma | 8.4 ± 0.5 | 9.2 ± 0.8 | 14.3 ± 5.0 | 7.6 ± 2.0 | 5.6 ± 1.1 | 6.5 ± 3.4 |
Arthritis | 45.1 ± 1.2 | 43.4 ± 1.4 | 34.7 ± 6.9 | 44.5 ± 3.4 | 51.3 ± 2.4 | 58.8 ± 8.3 |
Pneumonia | 2.9 ± 0.4 | 2.8 ± 0.4 | 4.0 ± 3.5 | 2.4 ± 0.9 | 3.5 ± 0.7 | 0.5 ± 0.5 |
Back pain | 24.0 ± 0.9 | 23.3 ± 1.0 | 24.8 ± 4.8 | 25.1 ± 2.8 | 25.0 ± 2.2 | 33.6 ± 6.9 |
Chronic bronchitis | 9.4 ± 0.6 | 8.9 ± 0.9 | 9.5 ± 4.8 | 8.9 ± 1.7 | 10.9 ± 1.5 | 9.6 ± 5.3 |
Total medical costs (2010$)b | 7200 ± 270 | 6100 ± 370 | 9200 ± 1790 | 7900 ± 900 | 9300 ± 650 | 18,600 ± 4520 |